Document is current
Any future updates will be listed below
-
Authors
Melikyan, Zarui A. http://orcid.org/0000-0002-8495-5546
Malek-Ahmadi, Michael http://orcid.org/0000-0001-9901-3650
O’Connor, Kathleen
Atri, Alireza
Kawas, Claudia H.
Corrada, María M. http://orcid.org/0000-0002-8168-8593
-
Funding
Funding for this research was provided by:
National Institute on Aging (R01AG021055)
Arizona Department of Health Services and Arizona Alzheimer's Consortium (CTR040636)
- License Information
-
More Information
Article History
Received: 23 October 2020
Accepted: 10 May 2021
First Online: 29 May 2021
Declarations
:
: C.H.K., M.M.C., Z.A.M., M.M.A., K.O. have no conflict of interest to declare. A.A. has received unrelated institutional grant funding from Alzheimer’s Clinical Trials Consortium (ACTC), Alzheimer’s Therapeutics Research Institute (ATRI), Alzheimer’s Prevention Initiative (API), Arizona Alzheimer’s Research Consortium, Global Alzheimer’s Platform (GAP), Novartis, University of Indiana (with ATRI, NIH, Alzheimer’s Association), University of Southern California (with ATRI, NIH, Alzheimer’s Association or Department of Defense). A.A. has received consulting fees and honoraria from Acadia, Alzheimer’s Association, Biogen, Eisai, Grifols, Harvard Medical School Post Graduate Education, NIH, Novo Nordisk, Roche/Genentech, Suven, and Synexus; and royalties from Oxford University Press.
: The study was approved by the Western Institutional Review Board. Research was completed in accordance with the Helsinki Declaration.
: All participants provided signed informed consent.
: All authors agree to this publication.
